Your browser doesn't support javascript.
loading
A brief history of and future prospects for pneumococcal vaccination in Malaysia.
Lister, Alex J J; Dombay, Evelin; Cleary, David W; Sulaiman, Lokman H; Clarke, Stuart C.
Afiliación
  • Lister AJJ; Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Dombay E; Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Cleary DW; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Sulaiman LH; NIHR Birmingham Biomedical Research Centre, Institute of Translational Medicine, Birmingham, Birmingham, UK.
  • Clarke SC; Centre for Environment and Population Health, Institute for Research, Development, and Innovation, International Medical University, Kuala Lumpur, Malaysia.
Pneumonia (Nathan) ; 15(1): 12, 2023 Aug 25.
Article en En | MEDLINE | ID: mdl-37620925
ABSTRACT
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pneumonia (Nathan) Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pneumonia (Nathan) Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido